Literature DB >> 4270988

The pharmacology of AH8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug.

R T Brittain, M B Tyers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4270988     DOI： 10.1093/bja/45.8.837

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  6 in total

1.  Sir David Jack: an extraordinary drug discoverer and developer.

Authors:  Clive Page; Patrick Humphrey
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

2.  Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.

Authors:  R Hughes; J P Payne; N Sugai
Journal:  Can Anaesth Soc J       Date:  1976-01

3.  Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

4.  A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants.

Authors:  A T Birmingham; S Z Hussain
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

5.  AH 10407: a novel, short-acting, competitive neuromuscular blocking drug in animals and man.

Authors:  C E Blogg; R T Brittain; B R Simpson; M B Tyers
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

6.  Pharmacological and certain chemical properties of AH 10407, an unusually short-acting, competitive neuromuscular blocking drug, and some related compounds.

Authors:  R T Brittain; D Jack; M B Tyers
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.